FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/12/030163 [Registered on: 31/12/2020] Trial Registered Retrospectively
Last Modified On: 18/12/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparing the efficacy of two local anaesthetic agents (levobupivacaine and ropivacaine) with routinely used bupivacaine local anaesthetic for cesarean delivery by spinal anaesthesia. 
Scientific Title of Study   SPINAL ANESTHESIA FOR ELECTIVE CAESAREAN SECTION- COMPARISION OF LEVOBUPIVACAINE AND ROPIVACAINE WITH HYPERBARIC RACEMIC BUPIVACAINE  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Melwin George 
Designation  Consultant  
Affiliation  Malankara Orthodox Syrian Church Medical College 
Address  Department of Critical Care Medicine
3rs floor Medical Intensive Care Unit RAJAGIRI HOSPITAL
Thrissur
KERALA
683112
India 
Phone  9995238342  
Fax    
Email  drmelwing@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shaloo Ipe  
Designation  HOD and Professor 
Affiliation  MOSC medical college 
Address  Department of anesthesiology
Malankara Orthodox Syrian Church Medical College kolenchery Ernakulam
Ernakulam
KERALA
682311
India 
Phone  9495126722  
Fax    
Email  shaloo_ipe@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shaloo Ipe  
Designation  HOD and professor 
Affiliation  MOSC medical college 
Address  Department of Anesthesiology
Malankara Orthodox Syrian Church Medical College kolenchery Ernakulam
Ernakulam
KERALA
682311
India 
Phone  9495126722  
Fax    
Email  shaloo_ipe@yahoo.com  
 
Source of Monetary or Material Support  
Aesmira Life Sciences 
Malankara Orthodox Syrian Church Medical College Hospital Pharmacy  
Neon LABORATORIES LTD 
 
Primary Sponsor  
Name  Malankara Orthodox Syrian Church Medical College 
Address  Medical College Road Kolenchery PO Ernakulam 682311 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Melwin George  Malankara Orthodox Syrian Church Medical College  Department of Anesthesiology MOSC Medical college
Ernakulam
KERALA 
9995238342

drmelwing@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committe   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 1||Obstetrics,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Heavy Bupivacaine  Dose: 0.5% Heavy Bupivacaine 1.8ml + Fentanyl 25mcg(.5ml) Frequency/duration: single shot Route: intrathecal  
Intervention  Levobupivacaine   Dose: 0.5% Levobupivacaine 1.8ml + Fentanyl 25mcg(.5ml) Frequency/duration: single shot Route: intrathecal  
Intervention  Ropivacaine   Dose: 0.5% Ropivacaine 1.8ml + Fentanyl 25mcg(.5ml) Frequency/duration: single shot Route: intrathecal  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. ASA 1 Parturient
2. Height 145-175cms
3. Singleton term pregnancy
4. Elective caesarean section 
 
ExclusionCriteria 
Details  1. Parturient refusal
2. Local infection
3. Coagulopathy
4. Allergy to the study drugs
5. Any neurological deficit
6. Multifoetal gestation 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Anesthetic efficacy of study drugs
comaprison of sensory, motor charactersitics of the study drug
complications
neonatal outcome  
1. Sensory assessment: every 2 min from 2 to 20 min and then every 10min until recovery to T12
2. Motor assessment: at baseline, then 2, 4, 6, 10, 15, and 20 mins after intrathecal injection and as soon as possible at the end of surgery. Every 10min after surgery.
3. Hemodynamics: at 2-minute intervals for 20 mins and 10 mins interval throughout the surgery and one-hour interval up to six hours postoperatively 
 
Secondary Outcome  
Outcome  TimePoints 
SEVERITY OF COMPLICATION   DURING FIRST 20MINUTES AFTER THE SPINAL ANESTHESIA 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "90"
Final Enrollment numbers achieved (India)="90" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/12/2012 
Date of Study Completion (India) 09/12/2014 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NOT YET 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Abstract 
Background: Spinal anaesthesia is a popular technique for caesarean section. Our study was designed to determine the efficacy and safety of newer local anaesthetics, Levobupivacaine and Ropivacaine and compare it with commonly used Hyperbaric Bupivacaine for spinal anaesthesia in elective caesarean section.

Method: In this prospective, randomized controlled, double-blind study, 90 parturients were allocated to three groups of 30 each. Group A (control) received 0.5% Hyperbaric Bupivacaine 1.8ml with 25mcg Fentanyl, Group B (study) received 0.5% Levobupivacaine 1.8ml with 25mcg with Fentanyl, Group C (study) received 0.75% Ropivacaine 1.8ml with 25mcg Fentanyl. The study drug was considered effective if an upper sensory level of T6 or above was achieved and if intraoperative supplementation was not required for successful completion of surgery. Parturients hemodynamic parameters, sensory, motor characteristics and complications as well as neonatal safety were assessed. 

Results: Anaesthesia was effective in 96.7% of parturients in A and C groups and 80% in B group. Duration of motor block was shorter in B (112.83±21.57mins P=.000) and C (122.06±19.84mins P=.016) groups compared to A group (136.96±18.87mins). Mean duration of analgesia was lesser in B (208.33±44.54mins, P=.001) and C (218.62±21.91mins, P=.010) groups when compared to A (245.96±35.99mins). Episodes of intraoperative hypotension and the amount of Ephedrine consumed were higher in C group compared to group A (P=0.039). Maternal and neonatal outcomes were satisfactory in all the three groups. 

Conclusion: Ropivacaine 0.75% was as efficacious as Hyperbaric Bupivacaine 0.5% in providing satisfactory spinal anaesthesia for caesarean section. Levobupivacaine 0.5% was found to be inferior to Bupivacaine and Ropivacaine in terms of efficacy. Duration of analgesia and duration of motor blockade was shorter with Levobupivacaine and Ropivacaine when compared to Bupivacaine. Maternal and neonatal safety were ensured in all the three groups. 

Keywords: Bupivacaine; Levobupivacaine; Ropivacaine; Fentanyl; spinal anaesthesia; caesarean section.
 
Close